Bermuda Cancer Genetics and Risk Assessment Clinic
Mutations in certain genes – known as BRCA 1 and BRCA 2 – make Bermudian men and women from particular families more susceptible to developing breast and ovarian cancer than the island’s population at large. To decrease the morbidity and mortality from breast and ovarian cancers, Partners launched the Bermuda Cancer Genetics Risk Assessment Program in 2006 in collaboration with the Health Insurance Association of Bermuda and the Bermuda Cancer and Health Centre. As the island’s first program for cancer genetics testing, the initiative identifies, educates and supports women who may be at high risk. Once it has been determined that a patient is at high risk, Dr. Kevin Hughes, a leading breast specialist from Massachusetts General Hospital, develops a plan of care in collaboration with the patient’s local doctor. Genetic testing, earlier mammography, and more frequent clinical exams are all considered, depending upon the patient’s needs.
“Our program is primarily a patient education and evaluation service,” explained Dr. Hughes. “When we determine that a patient is at high risk, we will develop a plan of care in collaboration with her local doctor. Genetic testing, earlier mammography, and more frequent clinical exams will all be considered, depending upon the needs of the patient. Our goal is to identify patients at high risk, and to then take measures to either prevent cancer, or find it at an earlier, more treatable stage.”
The program is under the medical direction of Dr. Kevin Hughes fromMassachusetts GeneralHospital and is open to all men and women inBermuda who may be at risk for breast and ovarian cancer. It is offered in collaboration with the Health Insurance Association of Bermuda.
For more information about this program, or to request an appointment, please contact Leslie Shane, Partners’ local representative inBermuda at (441) 238-3620 or (617) 535-6556.
To submit your family history, go to: